Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New platelet aggregation inhibitors.

A Kawashima, Y Kishimura, M Tamai

    Chemical & Pharmaceutical Bulletin
    |December 1, 1989
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.

    The Journal of urology·2023
    Same author

    Nightlife clusters of coronavirus disease in Tokyo between March and April 2020.

    Epidemiology and infection·2020
    Same author

    Pathological role of excessive DNA as a trigger of keratinocyte proliferation in psoriasis.

    Clinical and experimental immunology·2020
    Same author

    Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients.

    Cancer gene therapy·2017
    Same author

    Prostate cancer: state of the art imaging and focal treatment.

    Clinical radiology·2017
    Same author

    Measurement of residual platelet thrombogenicity under arterial shear conditions in cerebrovascular disease patients receiving antiplatelet therapy.

    Journal of thrombosis and haemostasis : JTH·2016

    Researchers discovered three novel platelet aggregation inhibitors, PI-080, PI-085, and PI-087, from Streptomyces matensis. Their structures were elucidated using spectral and chemical analyses, offering potential new avenues for cardiovascular research.

    Area of Science:

    • Microbiology
    • Pharmacology
    • Organic Chemistry

    Background:

    • Platelet aggregation plays a critical role in thrombosis and cardiovascular diseases.
    • Natural products are a rich source of novel therapeutic compounds.

    Purpose of the Study:

    • To isolate and characterize new platelet aggregation inhibitors from Streptomyces matensis.
    • To elucidate the chemical structures of these novel compounds.

    Main Methods:

    • Culturing of Streptomyces matensis A-6621.
    • Isolation of active compounds using chromatographic techniques.
    • Structure elucidation via spectral (NMR, MS) and chemical methods.

    Main Results:

    • Three new platelet aggregation inhibitors, designated PI-080, PI-085, and PI-087, were successfully isolated.

    Related Experiment Videos

  • The chemical structures of PI-080, PI-085, and PI-087 were determined.

    • Conclusions:

    • Streptomyces matensis produces novel compounds with potential anti-platelet activity.
    • The identified inhibitors represent promising candidates for further investigation in anti-thrombotic drug development.